Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed375%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Pulmonary Hypertension and Measurement of Exercise Capacity Remotely

NCT04903704
completednot_applicable

Comparison of Functional Capacities of Healthcare Workers With and Without Covid-19

NCT04834739
unknown

Long-term Effects of COVID-19: a Comparative Cohort Study

NCT05002205
completednot_applicable

1STST and Muscle Weakness in CF Patients

NCT03117764

Clinical Trials (4)

Showing 4 of 4 trials
NCT04903704Not Applicable

Pulmonary Hypertension and Measurement of Exercise Capacity Remotely

Completed
NCT04834739Not Applicable

Comparison of Functional Capacities of Healthcare Workers With and Without Covid-19

Completed
NCT05002205

Long-term Effects of COVID-19: a Comparative Cohort Study

Unknown
NCT03117764Not Applicable

1STST and Muscle Weakness in CF Patients

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4